ATOR MARK A.,MARK A. ATOR,BIHOVSKY RON,RON BIHOVSKY,CHATTERJEE SANKAR,SANKAR CHATTERJEE,DUNN DEREK,DEREK DUNN,HUDKINS ROBERT L.,ROBERT L. HUDKINS
申请号：
PL363167
公开号：
PL226805B1
申请日:
2001.05.09
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The present invention is directed to novel multicyclic molecules of formula Ia that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
